Navigation Links
Concurrent imaging of metabolic and electric signals in the heart
Date:10/23/2009

Cardiac rhythm disorders can result from disturbances in cardiac metabolism. These metabolic changes are tightly linked with specific cardiac electrophysiology (CEP) abnormalities, such as depressed excitability, impaired intra- and extracellular conductivities, wave propagation block, and alteration of conduction velocity, action potential amplitude, and duration. The altered electrophysiology eventually can lead to arrhythmias, fibrillation, and cardiac death; therefore, understanding the spatiotemporal complexity of the relationship between metabolism and electrophysiology is the challenge in developing new approaches for treatment of cardiac diseases. The optical system for simultaneous imaging electrical and metabolic quantities in the heart was developed by scientists at Vanderbilt University. The advantages of their imaging system over others include an optional software camera calibration routine that eliminates the need for precise camera alignment. The system allows for rapid setup, dichroic image separation, dual-rate imaging, and high spatial resolution, and it is generally applicable to any two-camera measurement. The authors provide a detailed description of a camera calibration algorithm along with multiple examples. They demonstrate the capabilities of this type of imaging system for recording not only the transmembrane potential and intracellular calcium, but other signals more directly related to myocardial metabolism, such as [K+]e, NADH, and reactive oxygen species, leading to the possibility of correlative multimodal cardiac imaging. The authors findings appear in the November issue of Experimental Biology and Medicine.

"The challenge in understanding cardiac rhythm disorders is to discern the dynamic relationship between multiple cardiac variables," John Wikswo notes. "This dual camera system opens up a new window for correlating metabolic and electrophysiological events, usually studied independently."

Veniamin Sidorov expects that "the measurement of multiple cardiac parameters during cardiac ischemia or hyperkalemia may enable the screening of new drugs that can be used to adjust electrical and contractile activities of the heart more precisely than commonly used ion-channel blockers/activators."

In summary, the development of metabolic therapies for CEP abnormalities requires simultaneous observation of CEP and metabolism, and a mechanistic understanding of their relationship. The authors' analysis of the potential for dual camera systems and implementations advances the understanding of "electrometabolic" cardiac disorders and their clinical treatment, and their review of related efforts to extend the optical measurements of myocardial function suggests that this is a field worthy of expanded research.

Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medicine said "This technological advance allows the simultaneous measurement of changes in the electrical properties and metabolic profile of the same region of the heart. The ability to measure these coupled phenomena will improve our mechanistic understanding of various cardiac abnormalities including heart failure, fatal arrhythmias, and rate-dependent cardiac remodeling."


'/>"/>

Contact: Veniamin Y. Sidorov
v.sidorov@vanderbilt.edu
615-322-4419
Society for Experimental Biology and Medicine
Source:Eurekalert

Related biology news :

1. NSF funds states first imaging system for UAB microscale research lab
2. New Automatic cell feeding station PROcellcare for life cell imaging
3. Scary ancient spiders revealed in 3-D models, thanks to new imaging technique
4. Jet-propelled imaging for an ultrafast light source
5. Kornberg Associates Architects Selected to Develop Design for New Stanford University Imaging Center
6. Lyncean Technologies Inc. receives $1.2 M from NCRR to develop new imaging technique
7. First neuroimaging study examining motor execution in children with autism reveals new insights
8. Ultrasound imaging now possible with a smartphone
9. SNM Symposium on Multimodality Cardiovascular Molecular Imaging
10. Fattysaurus or thinnysaurus? How dinosaurs measure up with laser imaging
11. Studies on imaging and tracking transplanted cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
(Date:3/24/2017)... -- The Controller General of Immigration from Maldives Mr. ... have received the prestigious international IAIR Award for the most innovative high ... ... Maldives Immigration Controller ... (small picture on the right) have received the IAIR award for the ...
(Date:3/23/2017)... 23, 2017 Research and Markets has announced ... & Trends - Industry Forecast to 2025" report to their ... The ... CAGR of around 8.8% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
Breaking Biology News(10 mins):
(Date:9/22/2017)... ... 22, 2017 , ... Brain State Technologies®, a leading neurotechnology ... will be used to fund production of the company’s new B2v2® brainwave balancing ... nearly 1,000%. , The B2v2 is the world’s first brain-mirroring wellness product for ...
(Date:9/21/2017)... ... September 21, 2017 , ... Vixiar Medical announced ... and manufacturing functions to The LaunchPort™ Accelerator at the City Garage in Port ... of manufacturing and business services to its Residents. , Vixiar Medical recently ...
(Date:9/21/2017)... ... 21, 2017 , ... Today, BioPharma Institute, a leading training ... of 5 new courses to its prospectus. These include the eagerly-awaited Regulation ... 11 on Electronic Records and Electronic Signatures (Part 11 of Title 21 of ...
(Date:9/20/2017)... ... September 20, 2017 , ... Cybrexa ... Vishwas Paralkar to the role of chief scientific officer. In this role, Dr. ... to Cybrexa’s president and CEO, Per Hellsund. , “I was impressed with Cybrexa’s ...
Breaking Biology Technology: